Effects of Biejia Ruangan Tablet-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts

Chinese Journal of Integrative Medicine

Volumn 21, Issue 2, 2015, Pages 152-156

  Zhou, Jin ^a   Chen, Xiang mei ^a   Liu, Shu wen ^a   Fu, Bo ^a   Hong, Quan ^a   Wang, Shu juan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Biejia Ruangan Tablet; matrix metalloproteinase 9; renal interstitial fibroblasts; tissue inhibitor of metalloproteinase 1; type I and III procollagen

Indexed keywords

BIEJIA RUANGAN; GELATINASE B; HERBACEOUS AGENT; MESSENGER RNA; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 3; TABLET;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; KIDNEY FIBROSIS; KIDNEY INTERSTITIUM; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TABLET; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; KIDNEY; METABOLISM; SERUM; SPRAGUE DAWLEY RAT;

ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; COLLAGEN TYPE III; DRUGS, CHINESE HERBAL; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; MALE; MATRIX METALLOPROTEINASE 9; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SERUM; TABLETS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84925461276     PISSN: 16720415     EISSN: 19930402     Source Type: Journal    
DOI: 10.1007/s11655-014-1784-0     Document Type: Article

References (15)

1. Zhou GD, Li WS, Zhao JM, Sun YL, Pan D, Yang JF, et al. Clinical pathological study on the mechanism of effect of Fufang Biejia Ruangan Tablet in treatment of liver fibrosis. Med J Chin PLA (Chin) 2004;29:563–564.
2. Ke W, Zhu JH. Progresses of research in method of serum-pharmacology of Chinese herbs. Guide China Med (Chin) 2011;9:24–26.
3. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damages. Am J Kidney Dis 1992;20:1–17.
4. Kramann R, Dirocco DP, Maarouf OH, Humphreys BD. Matrix producing cells in chronic kidney disease: origin, regulation, and activation. Curr Pathobiol Rep 2013;1:26–27.
5. Docherty NG, Godson C. Fibrinogen as a damage-associated mitogenic signal for the renal fibroblast. Kidney Int 2011;80:1014–1016.
6. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996;7:2495–2508.
7. Reynolds JJ. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation. Oral Dis 1996;2:70–76.
8. López-Hernández FJ, López-Novoa JM. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects. Cell Tissue Res 2012;347:141–154.
9. Cai ZH, Liu W, Li Q, Wu XL, Qian YL, Cao YL. Blocking transforming growth factor β1 signaling decreases dermal fibroblast proliferation and type I collagen production. Chin J Exp Surg (Chin) 2003;20:160–161.
10. Lin HY, Wang HM, Zhu C. Regulation of matrix metalloproteinases and their tissue inhibitors by transforming growth factor-β. Prog Biochem Biophy (Chin) 2003;30:7–12.
11. Han Y P, Tuan T L, Hughes M, Shaw MC, Garner WL. Transforming growth factor-β1 and tumor necrosis factor-α-mediated induction and priteolytic activation of MMP-9 in human skin. J Biol Chem 2001;276:22341–22350.
12. Johansson N, Ala-aho R, Uitto V, Grénman R, Fusenig NE, López-Otín C, et al. Expression of collagenase-3 (MMP-3) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000;113:227–235.
13. Martin J, Steadman R, Knowlden J, Williams J, Davies M. Differential regulation of matrix metalloproteinases and their inhibitors in human golmerular epithelial cells in vitro. J Am Soc Nephrol 1998;9:1629–1637.
14. Chen DY, Yang YP. Clinical observation of phase II of therapeutic effect of composed Amyda Sinensis Soft Liver Tablet on hepatic fibrosis of chronic hepatitis B. Infect Dis Inf (Chin) 1999;12:61–62.
15. Shen WZ, Xie ZW, Cai JH, Lu HM, Lv HM. Effect of Complex Biejia Ruangan Tablet on renal transforming growth factor-β1 expression in rat model with chronic renal failure. Chin J Integr Tradit West Nephrol (Chin) 2006;7:570–573.